Compound Detail
CHEMBL3634131
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL3634131 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | YZPOQCQXOSEMAZ-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
271.1
MW (Da)
3.31
ALogP
3
HBA
1
HBD
36.4
PSA (Ų)
0.91
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 5.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | EC50 | 5.7 | 5.7 | 2000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | EC50 | = | 2000.0 | nM | 5.7 | Reversal of Zn-induced human soluble amyloid beta (1 to 42) aggregation after 30... | 26396692 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 34865870 | 10.1016/j.ejmech.2021.113975 | Unchecked | 3 |
| 26396692 | 10.1021/acsmedchemlett.5b00281 | SH-SY5Y | 2 |
| 26396692 | 10.1021/acsmedchemlett.5b00281 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine